LITHOSTAT

This brand name is authorized in United States

Active ingredients

The drug LITHOSTAT contains one active pharmaceutical ingredient (API):

1 Acetohydroxamic acid UNII 4RZ82L2GY5 - ACETOHYDROXAMIC ACID

Acetohydroxamic acid (AHA) is a stable, synthetic compound derived from hydroxylamine and ethyl acetate. Its molecular structure is similar to urea. AHA reversibly inhibits the bacterial enzyme urease, thereby inhibiting the hydrolysis of urea and production of ammonia in urine infected with urea-splitting organisms. The reduced ammonia levels and decreased pH enhance the effectiveness of antimicrobial agents and allow an increased cure rate of these infections. Read about Acetohydroxamic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LITHOSTAT Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BX03	Acetohydroxamic acid	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BX Other urologicals
Discover more medicines within G04BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 0178-0500